Zobrazeno 1 - 10
of 137
pro vyhledávání: '"Gustavo J. Rodrigo"'
Autor:
Gustavo J. Rodrigo, Carlos Rodrigo
Publikováno v:
Revista Médica del Uruguay, Vol 19, Iss 1 (2003)
Se realiza una revisión sobre el tratamiento inhalatorio de la crisis asmática. La inhaloterapia está ampliamente difundida en la práctica médica habitual, implicando importantes costos económicos. Sin embargo, se estima a nivel mundial que hay
Externí odkaz:
https://doaj.org/article/8d16bca247bc42b5b65460dd098e0c29
Autor:
Anahí Yáñez, Sang-Hoen Cho, Joan B Soriano, Lanny J Rosenwasser, Gustavo J Rodrigo, Klaus F Rabe, Stephen Peters, Akio Niimi, Dennis K Ledford, Rohit Katial, Leonardo M Fabbri, Juan C Celedón, Giorgio Walter Canonica, Paula Busse, Louis-Phillippe Boulet, Carlos E Baena-Cagnani, Qutayba Hamid, Claus Bachert, Ruby Pawankar, Stephen T Holgate
Publikováno v:
World Allergy Organization Journal, Vol 7, Iss , Pp - (2014)
In the past, asthma was considered mainly as a childhood disease. However, asthma is an important cause of morbidity and mortality in the elderly nowadays. In addition, the burden of asthma is more significant in the elderly than in their younger cou
Externí odkaz:
https://doaj.org/article/6cccbfc0c77f406aa44722fc96ba4a17
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice. 6:987-995
Background Inefficient inhaler technique (IT) compromises the optimal delivery of medication. However, the IT knowledge of health care professionals (HCPs) has received scant attention. Objective The objective of this study was to perform a systemati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::117245c138371db9c46884625e0c5113
https://doi.org/10.1016/j.jaip.2017.12.032
https://doi.org/10.1016/j.jaip.2017.12.032
Autor:
Gustavo J. Rodrigo
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 18:38-43
PURPOSE OF REVIEW To provide a fast overview about the introduction and development of anticholinergic drugs in Western medicine to their current indications particularly in asthma. RECENT FINDINGS Although short-acting muscarinic antagonists have be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c86f696f106fce0e5b020fedde41fc27
https://doi.org/10.1097/aci.0000000000000408
https://doi.org/10.1097/aci.0000000000000408
Autor:
David Price, Pablo Altman, Konstantinos Kostikas, Gustavo J Rodrigo, Dave Singh, Antonio Anzueto, Francesco Patalano, Robert Fogel, Giovanni Bader
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Gustavo J Rodrigo,1 David Price,2,3 Antonio Anzueto,4,5 Dave Singh,6 Pablo Altman,7 Giovanni Bader,8 Francesco Patalano,8 Robert Fogel,7 Konstantinos Kostikas8 1Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay;
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a515da86325caefef02d3fb52b133e
https://doi.org/10.2147/copd.s130482
https://doi.org/10.2147/copd.s130482
Autor:
Hugo Neffen, Gustavo J. Rodrigo
Publikováno v:
Pulmonary Pharmacology & Therapeutics. 42:1-6
Background Current guidelines recommend the use of inhaled corticosteroids/long-acting beta2-agonists as first-line therapy for COPD patients at risk for acute exacerbations and/or severe airflow limitation. This systematic review assesses available
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0147241cd7a561f82533a99e00e9b400
https://doi.org/10.1016/j.pupt.2016.11.003
https://doi.org/10.1016/j.pupt.2016.11.003
Publikováno v:
Current Opinion in Allergy & Clinical Immunology. 17:36-41
Purpose of review To illustrate the scant evidence and the shortcomings of the concept of 'asthma-COPD overlap syndrome' (ACOS) in terms of clinical utility. Recent findings Asthma and chronic obstructive pulmonary disease (COPD) are considered as tw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f761171d546ad0f9fd1ea0d36584b59
https://doi.org/10.1097/aci.0000000000000326
https://doi.org/10.1097/aci.0000000000000326
Autor:
César Picado, Berta Juliá, Jose Antonio Castillo Vizuete, Cristina Fernández, Joaquim Mullol, Gustavo J. Rodrigo, Vicente Plaza
Publikováno v:
Tobacco, smoking control and health educ..
Although smoking habit has been related to bad control of asthma and associated to chronic rhinosinusitis (CRS) (Hastan 2011), data on harmful effects of tobacco smoke on asthma and upper airways diseases are still inconsistent. We sought to investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd132f8f91be4bc2ff1ca58bc1102533
https://doi.org/10.1183/13993003.congress-2019.pa1688
https://doi.org/10.1183/13993003.congress-2019.pa1688
Autor:
Gustavo J. Rodrigo, Vicente Plaza
Publikováno v:
Annals of Allergy, Asthma & Immunology. 116:565-570
Background Fluticasone furoate and vilanterol is a new inhaled corticosteroid (ICS) and long-acting β 2 -agonist (LABA) combination developed for once-daily administration via a dry powder inhaler. Objective To assess the efficacy and safety of flut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6ac962151e2c1d5d9e4fabcd2026295
https://doi.org/10.1016/j.anai.2016.03.035
https://doi.org/10.1016/j.anai.2016.03.035
Autor:
Cristina Fernández, Gustavo J. Rodrigo, Jose Antonio Castillo Vizuete, César Picado, Joaquim Mullol, Vicente Plaza, Berta Juliá
Publikováno v:
Clinical Problems.
Rhinitis and chronic rhinosinusitis (CRS) are frequently associated with asthma and CRS with severe asthma. Loss of smell (LoS) is associated with CRS, specially with nasal polyps. We aimed to assess the reliability of LoS to discriminate severe from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e25445d8ae0a81b5a13429d9fc0ae237
https://doi.org/10.1183/13993003.congress-2018.pa3984
https://doi.org/10.1183/13993003.congress-2018.pa3984